Skip to main content Skip to secondary navigation

Responding to a Global Pandemic

ChEM-H supports the Innovative Medicines Accelerator to address the unique challenges of the COVID-19 pandemic.

COVID-19 Response

The global COVID-19 pandemic has changed the landscape of basic and translational research.

ChEM-H supports the newly-established Innovative Medicines Accelerator (IMA), a new initiative that aims to help Stanford researchers quickly turn breakthroughs into new ways to help patients. ChEM-H and IMA jointly awarded seed grants to in the areas of drug and vaccine prototype development, and outpatient studies. ChEM-H also supported the Stanford RISE (Respond. Innovate. Scale. Empower.) Awards for faculty and trainees to address the urgent and complex medical, economic, policy and societal needs of today and the future.

Call for COVID-19 Drug and Vaccine Prototyping Proposals

Deadline: November 2, 2020

Apply Now

Looking to participate in COVID-19 clinical studies at Stanford?

Visit Treat COVID

Looking for updates on COVID-19 policies on Stanford's campus?

Subscribe to Health Alerts